Originalarbeiten

Aerobic exercise increases hippocampal subfield volumes in younger adults and prevents volume decline in the elderly. Frodl T, Strehl K, Carballedo A, Tozzi L, Doyle M, Amico F, Gormley J, Lavelle G, O'Keane V. Brain Imaging Behav. 2020; epub ahead of print (Impact Factor: 3.418). PMID: 30927200

Interactive impact of childhood maltreatment, depression, and age on cortical brain structure: mega-analytic findings from a large multi-site cohort.Tozzi L, Garczarek L, Janowitz D, Stein DJ, Wittfeld K, Dobrowolny H, Lagopoulos J, Hatton SN, Hickie IB, Carballedo A, Brooks SJ, Vuletic D, Uhlmann A, Veer IM, Walter H, Bülow R, Völzke H, Klinger-König J, Schnell K, Schoepf D, Grotegerd D, Opel N, Dannlowski U, Kugel H, Schramm E, Konrad C, Kircher T, Jüksel D, Nenadić I, Krug A, Hahn T, Steinsträter O, Redlich R, Zaremba D, Zurowski B, Fu CHY, Dima D, Cole J, Grabe HJ, Connolly CG, Yang TT, Ho TC, LeWinn KZ, Li M, Groenewold NA, Salminen LE, Walter M, Simmons AN, van Erp TGM, Jahanshad N, Baune BT, van der Wee NJA, van Tol MJ, Penninx BWJH, Hibar DP, Thompson PM, Veltman DJ, Schmaal L, Frodl T; ‘for the ENIGMA-MDD Consortium’. Psychol Med. 2019;14:1-12. (Impact Factor: 5.641). PMID: 31084657

Longitudinal diffusion weighted imaging of limbic regions in patients with majordepressive disorder after 6 years and partial to full remission. Doolin K, Andrews S, Carballedo A, McCarthy H, O'Hanlon E, Tozzi L, Frodl T. Psychiatry Res Neuroimaging. 2019;287:75-86. (Impact Factor: 2.270). PMID: 31004996

Effects of early life adversity and FKBP5 genotype on hippocampal subfields volume in major depression. Mikolas P, Tozzi L, Doolin K, Farrell C, O'Keane V, Frodl T. J Affect Disord. 2019;252:152-159. (Impact Factor: 4.084). PMID: 30986730

Epigenetic Changes of FKBP5 as a Link Connecting Genetic and Environmental Risk Factors with Structural and Functional Brain Changes in Major Depression. Tozzi L, Farrell C, Booij L, Doolin K, Nemoda Z, Szyf M, Pomares FB, Chiarella J, O'Keane V, Frodl T. Neuropsychopharmacology. 2018;43:1138-1145. (Impact Factor: 6.544). PMID: 29182159

Childhood adversity impacts on brain subcortical structures relevant to depression. Frodl T, Janowitz D, Schmaal L, Tozzi L, Dobrowolny H, Stein DJ, Veltman DJ, Wittfeld K, van Erp TGM, Jahanshad N, Block A, Hegenscheid K, Völzke H, Lagopoulos J, Hatton SN, Hickie IB, Frey EM, Carballedo A, Brooks SJ, Vuletic D, Uhlmann A, Veer IM, Walter H, Schnell K, Grotegerd D, Arolt V, Kugel H, Schramm E, Konrad C, Zurowski B, Baune BT, van der Wee NJA, van Tol MJ, Penninx BWJH, Thompson PM, Hibar DP, Dannlowski U, Grabe HJ. J Psychiatr Res. 2017;86:58-65. (Impact Factor: 4.000). PMID: 27918926

Functional magnetic resonance imaging correlates of emotion recognition and voluntary attentional regulation in depression: A generalized psycho-physiological interaction study. Tozzi L, Doolin K, Farrel C, Joseph S, O'Keane V, Frodl T. J Affect Disord. 2017;208: 535-544. (Impact Factor: 3.786). PMID: 27814960

Childhood-Diagnosed ADHD, Symptom Progression, and Reversal Learning in Adulthood. McCarthy H, Stanley J, Piech R, Skokauskas N, Mulligan A, Donohoe G, Mullins D, Kelly J, Johnson K, Fagan A, Gill M, Meaney J, Frodl T. J Attention Disord. 2018;22(6):561-570. (Impact Factor: 3.668). PMID: 27507767

DNA methylation of the serotonin transporter gene (SLC6A4) is associated with brain function involved in processing emotional stimuli. Frodl T, Szyf M, Carballedo A, Ly V, Dymov S, Vaisheva F, Morris D, Fahey C, Meaney J, Gill M, Booij L. Journal of Psychiatry and Neuroscience 2015;40(5):296-305. (Impact Factor: 5.365). PMID: 25825812

Longitudinal functional connectivity changes correlate with mood improvement after regular exercise in a dose-dependent fashion. Tozzi L, Carballedo A, Lavelle G, Doolin K, Doyle M, Amico F, McCarthy H, Gormley J, Lord A, O'Keane V, Frodl T. Eur J Neurosci. 2016;43(8):1089-1096. (Impact Factor: 2.832). PMID: 26929085.

BDNF Val66Met polymorphism in patterns of neural activation in individuals with MDD and healthy controls. Lisiecka DM, O'Hanlon E, Fagan AJ, Carballedo A, Morris D, Suckling J, Frodl T. J Affect Disord. 2015;184:239-244. (Impact Factor: 3.786). PMID: 26117067

The role of sexual abuse on functional neuroimaging markers associated with major depressive disorder. Skokauskas N, Carballedo A, Fagan A, Frodl T. World J Biol Psychiatry. 2015;16(7):513-520. (Impact Factor: 3.713). PMID: 26114449

Single-Nucleotide Polymorphism of the FKBP5 Gene and Childhood Maltreatment as Predictors of Structural Changes in Brain Areas Involved in Emotional Processing in Depression. Tozzi L, Carballedo A, Wetterling F, McCarthy H, O'Keane V, Gill M, Morris D, Fahey C, Meaney J, Frodl T. Neuropsychopharmacology. 2016;41(2):487-97. (Impact Factor: 6.544). PMID: 26076833

DNA methylation of the serotonin transporter gene in peripheral cells and stress-related changes in hippocampal volume: a study in depressed patients and healthy controls. Booij L, Szyf M, Carballedo A, Frey EM, Morris D, Dymov S, Vaisheva F, Ly V, Fahey C, Meaney J, Gill M, Frodl T. PLoS One. 2015;10(3):e0119061. doi: 10.1371/journal.pone.0119061. (Impact Factor: 2.766). PMID: 25781010

Wetterling F, McCarthy H, Tozzi L, Skokauskas N, O'Doherty JP, Mulligan A, Meaney J, Fagan AJ, Gill M, Frodl T. Impaired reward processing in the human prefrontal cortex distinguishes between persistent and remittent attention deficit hyperactivity disorder. Hum Brain Mapp. 2015;36(11):4648-63. (Impact Factor: 4.927). PMID: 26287509.

Dysregulation between emotion and theory of mind networks in borderline personality disorder. O'Neill A, D'Souza A, Samson AC, Carballedo A, Kerskens C, Frodl T. Psychiatry Research Neuroimaging. 2015;231(1):25-32. (Impact Factor: 2.455). PMID: 25482858

BDNF Val66Met genotype interacts with childhood adversity and influences the formation of hippocampal subfields. Frodl T, Skokauskas N, Frey EM, Morris D, Gill M, Carballedo A. Hum Brain Mapp. 2014;35(12):5776-5783. (Impact Factor: 4.927). PMID: 25044977

Expression of glucocorticoid inducible genes is associated with reductions in cornu ammonis and dentate gyrus volumes in patients with major depressive disorder. Frodl T, Carballedo A, Frey EM, O'Keane V, Skokauskas N, Morris D, Gill M, Hughes MM, Harkin A, Connor T. Dev Psychopathol. 2014;26(4 Pt 2):1209-1217. (Impact Factor: 4.357). PMID: 25422956

Childhood adversity, depression, age and gender effects on white matter microstructure: a DTI study. Ugwu ID, Amico F, Carballedo A, Fagan AJ, Frodl T. Brain Struct Funct. 2014;220(4):1997-2009. (Impact Factor: 4.231). PMID: 24744150

Effect of Childhood Maltreatment on brain structure in adult patients with major depressive disorder and healthy subjects. Chaney A, Carballedo A, Amico F, Fagan A, Skokauskas N, Meaney J, Frodl T. J Psychiatry Neurosci. 2014;39:50-59. (Impact Factor: 5.365) PMID: 23900024

Attention Network Hypoconnectivity with Default and Affective Network Hyperconnectivity in Adults Diagnosed with Attention-Deficit/Hyperactivity Disorder in Childhood. McCarthy H, Skokauskas N, Mulligan A, Donohoe G, Mullins D, Kelly J, Johnson K, Fagan A, Gill M, Meaney J, Frodl T. JAMA Psychiatry 2013; 70(12):1329-1337. (Impact Factor: 16.642). PMID: 24132732

Identifying a Consistent Pattern of Neural Function in Attention Deficit Hyperactivity Disorder. A Meta-Analysis. McCarthy H, Skokauskas, N, Frodl T. Psychological Medicine 2013; 13:1-12 (Impact Factor: 5.475) PMID: 23663382

Recruitment of the left hemispheric emotional attention neural network in risk for and protection from depression. Lisiecka DM, Carballedo A, Fagan AJ, Ferguson Y, Meaney J, Frodl T. J Psychiatry Neurosci. 2013;38:117-128. (Impact Factor: 5.365) PMID: 23010257

Magnetic resonance imaging in patients with borderline personality disorder: a study of volumetric abnormalities. O’Neill A, D’Souza A, Carballedo A, Josephs S, Kerskens C, Frodl T. Psychiatry Res Neuroim. 2013;213:1-10. (Impact Factor: 2.455) PMID: 23684978

Brain-derived neurotrophic factor Val66Met polymorphism and early life adversity affect hippocampal volume. Carballedo A, Morris D, Zill P, Fahey C, Reinhold E, Meisenzahl E, Bondy B, Gill M, Möller HJ, Frodl T.Am J Med Genet B Neuropsychiatr Genet. 2013;162(2):183-190. (Impact Factor: 3.016) PMID: 23341118

Neurotrophic tyrosine kinase polymorphism impacts white matter connections in patients with major depressive disorder. Murphy ML, Carballedo A, Fagan AJ, Morris D, Fahey C, Meaney J, Frodl T. Biol Psychiatry. 2012;72:663-670. (Impact Factor: 11.984) PMID: 22609366

Effect of Genetic Variant in BICC1 on Functional and Structural Brain Changes in Depression. Bermingham R, Carballedo A, Lisiecka D, Fagan A, Morris D, Fahey C, Donohoe G, Meaney J, Gill M, Frodl T. Neuropsychopharmacology. 2012;37:2855-2862. (Impact Factor: 6.544) PMID: 22910460

Reduced Expression of Glucocorticoid-inducible Genes GILZ and SGK-1 and High IL-6 Levels are associated with reduced Hippocampal Volumes in Major Depressive Disorder. Frodl T, CarballedoA, HughesMM, SalehK, FaganA, SkokauskasN, McLoughlinDM, MeaneyJ, O’KeaneV, ConnorTJ. Translational Psychiatry. 2012;13;2:e88. (Impact Factor: 4.691) PMID: 22832853

Impact of Family History and Depression on Amygdala Volume. Saleh K, CarballedoA, LisieckaD, FaganA, ConnollyG, BoyleG, Frodl T. Psychiatry Res Neuroim. 2012;203:24-30. (Impact Factor: 1.455) PMID: 22867951

Reduced fractional anisotropy in the uncinate fasciculus in patients with major depression carrying the met-allele of the Val66Met brain-derived neurotrophic factor genotype. Carballedo A, Amico F, Ugwu I, Fagan AJ, Fahey C, Morris D, Meaney JF, Leemans A, Frodl T. Am J Med Genet B Neuropsychiatr Genet. 2012;159B(5):537-548. (Impact Factor: 3.016) PMID: 22585743

Early life adversity is associated with brain changes in subjects at family risk for depression. Carballedo A, Lisiecka D, Fagan A, Saleh K, Ferguson Y, Connolly G, Meaney J, Frodl T. World J Biol Psychiatry. 2012;13:569-78. (Impact Factor: 3.713) PMID: 22515408

Meta-analysis of structural MRI studies in children and adults with attention deficit hyperactivity disorder indicates treatment effects. Frodl T, Skokauskas N. Acta Psychiatr Scand. 2012;125:114-126. (Impact Factor: 4.984) PMID: 22118249

Altered inhibition of negative emotions in subjects at family risk of major depressive disorder. Lisiecka DM, Carballedo A, Fagan AJ, Connolly G, Meaney J, Frodl T. J Psychiatr Res. 2012;46(2):181-188. (Impact Factor: 4.000) PMID: 22078646

Functional Anomalies in Healthy Individuals with 1st Degree Family History of Major Depressive Disorder. Amico F, Carballedo A, Lisiecka D, Fagan A, Boyle G, Frodl T. Biology of Mood and Anxiety Disorders. 2012; 2:1. PMID: 22738278

Effects of early life adversity on brain white matter diffusivity changes in subjects at risk for major depression. Frodl T, Carballedo A, Fagan A, Lisiecka D, Ferguson Y, Meaney J. J Psychiatry Neurosci. 2012; 37(1):37-45. (Impact Factor: 5.365) PMID: 22008179

Meta-analysis of diffusion tensor imaging (DTI) studies shows altered fractional anisotropy occurring in distinct brain areas in association with depression. Murphy M, Frodl T. Biology of Mood and Anxiety Disorders. 2011;1:3. PMID: 22738088

Functional connectivity of emotional processing in depression. Carballedo A, Scheuerecker J, Meisenzahl E, Schoepf V, Bokde A, Möller HJ, Doyle M, Wiesmann M, Frodl T. J Affect Disord. 2011; 134(1-3):272-279. (Impact Factor: 3.786) PMID: 21757239

Neural correlates of treatment outcome in major depression. Lisiecka D, Meisenzahl E, Scheuerecker J, Schoepf V, Whitty P, Chaney A, Moeller HJ, Wiesmann M, Frodl T. Int J Neuropsychopharmacol. 2011; 14:521-534. (Impact Factor: 3.981) PMID: 21205435

Brain activation predicts treatment improvement in patients with major depressive disorder. Samson AC, Meisenzahl E, Scheuerecker J, Rose E, Schoepf V, Wiesmann M, Frodl T. J Psychiatr Res. 2011;45:1214-1222. (Impact Factor: 4.000) PMID: 21477817

Different effects of mirtazapine and venlafaxine on brain activation: an open randomized controlled fMRI study. Frodl T, Scheuerecker J, Schoepf V, Linn J, Koutsouleris N, Bokde AL, Hampel H, Möller HJ, Brückmann H, Wiesmann M, Meisenzahl E. J Clin Psychiatry. 2011;72:448-457. (Impact Factor: 4.247) PMID: 20868630

Structural MRI Correlates for Vulnerability and Resilience in Major Depression. Amico F, Koutsouleris N, Reiser M, Moeller H-J, Meisenzahl EM, Frodl T. J Psychiatry Neuroscience. 2011;36:15-22. (Impact Factor: 5.365) PMID: 20964952

Anterior Cingulate Cortex Gray Matter Abnormalities in Adult ADHD: a Voxel-Based Morphometry Study. Amico F, Stauber S, Koutsouleris N, Frodl T. Psychiatry Research: Neuroimaging. 2011;191:31-35. (Impact Factor: 2.455) PMID: 21129938

Childhood stress, serotonin transporter gene and brain structures in major depression. Frodl T, Reinhold E, Koutsouleris N, Donohoe G, Bondy B, Reiser M, Möller HJ, Meisenzahl EM. Neuropsychopharmacology. 2010;35:1383-1390. (Impact Factor: 6.544) PMID: 20147891

Orbitofrontal Volume Reductions in Major Depression are related to Functional Changes during Emotion Recognition in Major Depression. Scheuerecker J, Meisenzahl EM, Koutsouleris N, Roesner M, Schöpf V, Linn J, Wiesmann M, Brückmann H, Möller H-J, Frodl T. J Psychiatry Neuroscience. 2010;35:311-320. (Impact Factor: 5.365) PMID: 20569645

Functional connectivity bias of the orbitofrontal cortex in drug-free patients with major depression. Frodl T, Bokde ALW, Scheuerecker J, Lisiecka D, Schoepf V, Hampel H, Möller H-J, Brückmann H, Wiesmann M, Meisenzahl E. Biol Psychiatry. 2010;67:161-167. (Impact Factor: 11.984) PMID: 19811772

Interaction of childhood stress with hippocampus and prefrontal cortex volume reduction in major depression. Frodl T, Reinhold E, Koutsouleris N, Reiser M, Meisenzahl EM. J Psychiatr Res. 2010;44:799-807. (Impact Factor: 4.000) PMID: 20122698

Amygdala Reduction in Patients with ADHD compared to Major Depression and Healthy Volunteers. Frodl T, Stauber J, Schaaff N, Koutsouleris N, Scheuerecker J, Ewers M, Omerovic M, MD, Opgen-Rhein M, Hampel H, Reiser M, Möller H-J, Meisenzahl E. Acta Psychiatrica Scandinavica. 2010;121(2):111-118. (Impact Factor: 4.984) PMID: 19878138

Prefrontal and anterior cingulum hyperactivity in explicit and implicit emotional tasks in patients with major depression as compared to healthy controls. Frodl T, Scheuerecker J, Albrecht J, Kleemann AM, Müller-Schunk S, Koutsouleris N, Möller H-J, Brückmann H, Wiesmann M, Meisenzahl E. World Journal of Biological Psychiatry. 2009;10:202-208. (Impact Factor: 3.713) PMID: 17965984

Reduced gray matter brain volumes are associated with variants of the serotonin transporter gene in major depression. Frodl T, Koutsouleris N, Bottlender R, Jäger M, Born C, Mörgenthaler M, Rupprecht R, Bondy B., Reiser M, Möller H-J, Meisenzahl EM. Mol Psychiatry. 2008;13:1093-1101. (Impact Factor: 11.640) PMID:19008895

Depression-related long-term Decline of Brain Morphology: Stress-toxicity? Frodl T, Koutsouleris N, Bottlender R, Jäger M, Born C, Scupin I, Reiser M, Möller H-J, Meisenzahl EM. Archives of General Psychiatry. 2008;65:1156-1165. (Impact Factor: 16.642) PMID:18838632

Effect of hippocampal and amygdala volumes on clinical outcomes in major depression: a 3-year prospective magnetic resonance imaging study. Frodl T, Jäger M, Smajstrlova I, Born C, Bottlender R, Koutsouleris N, Palladino T, Reiser M, Möller H-J, Meisenzahl EM. Journal of Psychiatry and Neuroscience. 2008;33:423-430. (Impact Factor: 5.365) PMID:18787661

Reduced Hippocampal Volumes associated with the Long Variant of the Tri- and Diallelic Serotonin Transporter Polymorphism in Major Depression. Frodl T, Zill P, Baghai T, Rujescu D, Leinsinger G, Bottlender R, Schüle C, Zwanzger P, Engel RR, Rupprecht R, Bondy B, Reiser M, Möller H-J, Meisenzahl EM. American Journal of Medical Genetics: Part B Neurogenetics. 2008;147B:1003-1007. (Impact Factor: 3.016) PMID: 18286634

Anterior cingulate cortex does not differ between patients with major depression and healthy controls, but relatively large anterior cingulate cortex predicts a good clinical course. Frodl T, Zetzsche T, Jäger M, Born C, Ritter S, Kraft E, Bottlender R, Leinsinger G, Reiser M, Möller H-J, Meisenzahl, E. Psychiatry Research & Neuroimaging. 2008;163:76-83. (Impact Factor: 2.455) PMID:18406580

Brain Derived Neurotrophic Factor Val66met Polymorphism is associated with reduced Hippocampal Volumes in Major Depression. Frodl T, Schüle C, Schmitt G, Born C, Baghai T, Zill P, Bottlender R, Rupprecht R, Bondy B, Reiser M, Möller H-J, Meisenzahl E. Archives of General Psychiatry. 2007;64:410-416. (Impact Factor: 16.642) PMID: 17404118

Reduced hippocampal volume correlates with executive dysfunctioning in major depression. Frodl T, Schaub A, Banac S, Charypar M, Jäger M, Kümmler P, Bottlender R, Zetzsche T, Leinsinger G, Reiser M, Möller H-J, Meisenzahl EM. Journal of Psychiatry and Neuroscience. 2006;31:316-322. (Impact Factor: 5.365) PMID:16951734

Reduced hippocampal volumes associated with the long variant of the serotonin transporter polymorphism in major depression. Frodl T, Meisenzahl EM, Zill P, Baghai T, Rujescu D, Leinsinger G, Bottlender R, Schüle C, Zwanzger P, Engel RR, Rupprecht R, Bondy B, Reiser M, Möller H-J. Archives of General Psychiatry. 2004;61:177-183. (Impact Factor: 16.642) PMID: 14757594

Hippocampal and amygdala changes in patients with major depressive disorders and healthy controls during a 1-year follow-up. Frodl T, Meisenzahl EM, Zetzsche T, Höhne T, Banac S, Schorr C, Jäger M, Leinsinger G, Bottlender R, Reiser M, Möller H-J. Journal of Clinical Psychiatry. 2004;65:492-499. (Impact Factor: 4.247) PMID:15119911

Larger amygdala volumes in first depressive episode as compared to recurrent major depression and healthy controls subjects. Frodl T, Meisenzahl EM, Zetzsche T, Born C, Jäger M, Groll C, Bottlender R, Leinsinger G, Möller H-J. Biological Psychiatry. 2003;53:338-344. (Impact Factor: 11.984) PMID:12586453

P300 subcomponents and clinical symptoms in schizophrenia. Frodl T, Meisenzahl EM, Müller D, Holder J, Juckel G, Möller H-J, Hegerl U. International Journal of Psychophysiology. 2002;43:237-246. (Impact Factor: 2.868) PMID: 11850089

Value of event-related P300 subcomponents in the clinical diagnosis of mild cognitive impairment and Alzheimer´s Disease? Frodl T, Hampel H, Juckel G, Bürger K, Padberg F, Engel RR, Möller H-J, Hegerl U. Psychophysiology. 2002;39:175-181. (Impact Factor: 3.118) PMID: 12212666

Enlargement of the amygdala in patients with a first episode of major depression. Frodl T, Meisenzahl EM, Zetzsche T, Bottlender R, Born C, Groll C, Jäger M, Leinsinger G, Hahn K, Möller H-J. Biological Psychiatry. 2002;51:708-714. (Impact Factor: 11.984) PMID: 11983184

Hippocampal changes in patients with a first episode of major depression. Frodl T, Meisenzahl EM, Zetzsche T, Born C, Groll C, Jäger M, Leinsinger G, Bottlender R, Hahn K, Möller H-J. American Journal of Psychiatry. 2002;159:1112-1118. (Impact Factor: 13.396) PMID: 12091188

The effect of the skull on event-related P300. Frodl T, Meisenzahl EM, Müller D, Leinsinger G, Juckel G, Hahn K, Möller H-J, Hegerl U. Clinical Neurophysiology. 2001;112:1773-1776. (Impact Factor: 3.614) PMID: 11514260

Corpus callosum and P300 in schizophrenia. Frodl T, Meisenzahl EM, Müller D, Greiner J, Juckel G, Leinsinger G, Hahn K, Möller H-J and Hegerl U. Schizophrenia Research. 2001;49:107-120. (Impact Factor: 3.958) PMID: 11343870

Dipole localization of P300 and normal aging. Frodl T, Juckel G, Gallinat J, Bottlender R, Riedel M, Preuss U, Möller HJ, Hegerl U. Brain Topography. 2000;13:3-9. (Impact Factor: 2.703) PMID: 11073089

P300 subcomponents reflect different aspects of psychopathology in schizophrenia. Frodl (Frodl-Bauch) T, Gallinat J, Meisenzahl EM, Möller H-J, Hegerl U. Biological Psychiatry. 1999;45:116-126. (Impact Factor: 11.984) PMID:9894583

Markers from event-related potential subcomponents and reaction time for information processing dysfunction in schizophrenia. Frodl T, Meisenzahl EM, Gallinat J, Hegerl U, Möller H-J. European Archives of Psychiatry and Clinical Neuroscience. 1998;248:307-313. (Impact Factor: 3.614) PMID: 9928910

Dipole source analysis of P300 component of the auditory evoked potential: a methodological advance? Hegerl U and Frodl (Frodl-Bauch) T. Psychiatry Research Neuroimaging. 1997;74:109-118. (Impact Factor: 2.455) PMID: 9204513

Dipole localization and test-retest reliability of frequency and duration mismatch negativity generator processes. Frodl (Frodl-Bauch) T, Kathmann N, Möller H-J, Hegerl U. Brain Topography. 1997;10:3-8. (Impact Factor: 2.703) PMID: 9358949

Javaheripour N, Li M, Chand T, Krug A, Kircher T, Dannlowski U, Nenadić I, Hamilton JP, Sacchet MD, Gotlib IH, Walter H, Frodl T, Grimm S, Harrison BJ, Wolf CR, Olbrich S, van Wingen G, Pezawas L, Parker G, Hyett MP, Sämann PG, Hahn T, Steinsträter O, Jansen A, Yuksel D, Kämpe R, Davey CG, Meyer B, Bartova L, Croy I, Walter M, Wagner G. Altered resting-state functional connectome in major depressive disorder: a mega-analysis from the PsyMRI consortium. Transl Psychiatry 2021;11(1):511. (Impact Factor: 6.222) PMID: 34620830.

Busse S, Hoffmann J, Michler E, Hartig R, Frodl T, Busse M. Dementia- associated changes of immune cell composition within the cerebrospinal fluid. Brain Behav Immun Health. 2021 Apr 20;14:100218. doi: 10.1016/j.bbih.2021.100218. PMID: 34589754. Roddy D, Kelly JR, Farrell C, Doolin K, Roman E, Nasa A, Frodl T, Harkin A, O'Mara S, O'Hanlon E, O'Keane V. Amygdala substructure volumes in Major Depressive Disorder. Neuroimage Clin. 2021; 31:102781. Epub 2021 Aug 8. (Impact Factor: 4.881) PMID: 34384996.

Leerssen J, Blanken TF, Pozzi E, Jahanshad N, Aftanas L, Andreassen OA, Baune BT, Brack I, Carballedo A, Ching CRK, Dannlowski U, Dohm K, Enneking V, Filimonova E, Fingas SM, Frodl T, Godlewska BR, Goltermann J, Gotlib IH, Grotegerd D, Gruber O, Harris MA, Hatton SN, Hawkins E, Hickie IB, Jaworska N, Kircher T, Krug A, Lagopoulos J, Lemke H, Li M, MacMaster FP, McIntosh AM, McLellan Q, Meinert S, Mwangi B, Nenadić I, Osipov E, Portella MJ, Redlich R, Repple J, Sacchet MD, Sämann PG, Simulionyte E, Soares JC, Walter M, Watanabe N, Whalley HC, Yüksel D, Veltman DJ, Thompson PM, Schmaal L, Van Someren EJW. Brain structural correlates of insomnia severity in 1053 individuals with major depressive disorder: results from the ENIGMA MDD Working Group. Transl Psychiatry 2020; 10(1):425. (Impact Factor: 6.222) PMID: 33293520.

O'Neill A, Carey E, Dooley N, Healy C, Coughlan H, Kelly C, Frodl T, O'Hanlon E, Cannon M. Multiple Network Dysconnectivity in Adolescents with Psychotic Experiences: A Longitudinal Population-Based Study. Schizophr Bull 2020; 46(6):1608-1618. (Impact Factor: 9.306) PMID: 32614036.

Thompson PM, Jahanshad N, Ching CRK, Salminen LE, Thomopoulos SI, Bright J, Baune BT, Bertolín S, Bralten J, Bruin WB, Bülow R, Chen J, Chye Y, Dannlowski U, de Kovel CGF, Donohoe G, Eyler LT, Faraone SV, Favre P, Filippi CA, Frodl T, Garijo D, Gil Y, Grabe HJ, Grasby KL, Hajek T, Han LKM, Hatton SN, Hilbert K, Ho TC, Holleran L, Homuth G, Hosten N, Houenou J, Ivanov I, Jia T, Kelly S, Klein M, Kwon JS, Laansma MA, Leerssen J, Lueken U, Nunes A, Neill JO, Opel N, Piras F, Piras F, Postema MC, Pozzi E, Shatokhina N, Soriano-Mas C, Spalletta G, Sun D, Teumer A, Tilot AK, Tozzi L, van der Merwe C, Van Someren EJW, van Wingen GA, Völzke H, Walton E, Wang L, Winkler AM, Wittfeld K, Wright MJ, Yun JY, Zhang G, Zhang-James Y, Adhikari BM, Agartz I, Aghajani M, Aleman A, Althoff RR, Altmann A, Andreassen OA, Baron DA, Bartnik-Olson BL, Marie Bas-Hoogendam J, Baskin- Sommers AR, Bearden CE, Berner LA, Boedhoe PSW, Brouwer RM, Buitelaar JK, Caeyenberghs K, Cecil CAM, Cohen RA, Cole JH, Conrod PJ, De Brito SA, de Zwarte SMC, Dennis EL, Desrivieres S, Dima D, Ehrlich S, Esopenko C, Fairchild G, Fisher SE, Fouche JP, Francks C, Frangou S, Franke B, Garavan HP, Glahn DC, Groenewold NA, Gurholt TP, Gutman BA, Hahn T, Harding IH, Hernaus D, Hibar DP, Hillary FG, Hoogman M, Hulshoff Pol HE, Jalbrzikowski M, Karkashadze GA, Klapwijk ET, Knickmeyer RC, Kochunov P, Koerte IK, Kong XZ, Liew SL, Lin AP, Logue MW, Luders E, Macciardi F, Mackey S, Mayer AR, McDonald CR, McMahon AB, Medland SE, Modinos G, Morey RA, Mueller SC, Mukherjee P, Namazova-Baranova L, Nir TM, Olsen A, Paschou P, Pine DS, Pizzagalli F, Rentería ME, Rohrer JD, Sämann PG, Schmaal L, Schumann G, Shiroishi MS, Sisodiya SM, Smit DJA, Sønderby IE, Stein DJ, Stein JL, Tahmasian M, Tate DF, Turner JA, van den Heuvel OA, van der Wee NJA, van der Werf YD, van Erp TGM, van Haren NEM, van Rooij D, van Velzen LS, Veer IM, Veltman DJ, Villalon-Reina JE, Walter H, Whelan CD, Wilde EA, Zarei M, Zelman V; ENIGMA Consortium. ENIGMA and global neuroscience: A decade of large-scale studies of the brain in health and disease across more than 40 countries. Transl Psychiatry 2020; 10(1):100. (Impact Factor: 6.222) PMID: 32198361.

Schmaal L, Pozzi E, C Ho T, van Velzen LS, Veer IM, Opel N, Van Someren EJW, Han LKM, Aftanas L, Aleman A, Baune BT, Berger K, Blanken TF, Capitão L, Couvy- Duchesne B, R Cullen K, Dannlowski U, Davey C, Erwin-Grabner T, Evans J, Frodl T, Fu CHY, Godlewska B, Gotlib IH, Goya-Maldonado R, Grabe HJ, Groenewold NA, Grotegerd D, Gruber O, Gutman BA, Hall GB, Harrison BJ, Hatton SN, Hermesdorf M, Hickie IB, Hilland E, Irungu B, Jonassen R, Kelly S, Kircher T, Klimes-Dougan B, Krug A, Landrø NI, Lagopoulos J, Leerssen J, Li M, Linden DEJ, MacMaster FP, M McIntosh A, Mehler DMA, Nenadić I, Penninx BWJH, Portella MJ, Reneman L, Rentería ME, Sacchet MD, G Sämann P, Schrantee A, Sim K, Soares JC, Stein DJ, Tozzi L, van Der Wee NJA, van Tol MJ, Vermeiren R, Vives-Gilabert Y, Walter H, Walter M, Whalley HC, Wittfeld K, Whittle S, Wright MJ, Yang TT, Zarate C Jr, Thomopoulos SI, Jahanshad N, Thompson PM, Veltman DJ. ENIGMA MDD: seven years of global neuroimaging studies of major depression through worldwide data sharing. Transl Psychiatry 2020; 10(1):172. (Impact Factor: 6.222) PMID: 32472038.

van Velzen LS, Kelly S, Isaev D, Aleman A, Aftanas LI, Bauer J, Baune BT, Brak IV, Carballedo A, Connolly CG, Couvy-Duchesne B, Cullen KR, Danilenko KV, Dannlowski U, Enneking V, Filimonova E, Förster K, Frodl T, Gotlib IH, Groenewold NA, Grotegerd D, Harris MA, Hatton SN, Hawkins EL, Hickie IB, Ho TC, Jansen A, Kircher T, Klimes-Dougan B, Kochunov P, Krug A, Lagopoulos J, Lee R, Lett TA, Li M, MacMaster FP, Martin NG, McIntosh AM, McLellan Q, Meinert S, Nenadić I, Osipov E, Penninx BWJH, Portella MJ, Repple J, Roos A, Sacchet MD, Sämann PG, Schnell K, Shen X, Sim K, Stein DJ, van Tol MJ, Tomyshev AS, Tozzi L, Veer IM, Vermeiren R, Vives-Gilabert Y, Walter H, Walter M, van der Wee NJA, van der Werff SJA, Schreiner MW, Whalley HC, Wright MJ, Yang TT, Zhu A, Veltman DJ, Thompson PM, Jahanshad N, Schmaal L. White matter disturbances in major depressive disorder: a coordinated analysis across 20 international cohorts in the ENIGMA MDD working group. Mol Psychiatry. 2020; 25(7):1511-1525. Epub 2019 Aug 30. (Impact Factor: 9.306) PMID: 31471575.

Hoogman M, Muetzel R, Guimaraes JP, Shumskaya E, Mennes M, Zwiers MP, Jahanshad N, Sudre G, Wolfers T, Earl EA, Soliva Vila JC, Vives-Gilabert Y, Khadka S, Novotny SE, Hartman CA, Heslenfeld DJ, Schweren LJS, Ambrosino S, Oranje B, de Zeeuw P, Chaim-Avancini TM, Rosa PGP, Zanetti MV, Malpas CB, Kohls G, von Polier GG, Seitz J, Biederman J, Doyle AE, Dale AM, van Erp TGM, Epstein JN, Jernigan TL, Baur-Streubel R, Ziegler GC, Zierhut KC, Schrantee A, Høvik MF, Lundervold AJ, Kelly C, McCarthy H, Skokauskas N, O'Gorman Tuura RL, Calvo A, Lera-Miguel S, Nicolau R, Chantiluke KC, Christakou A, Vance A, Cercignani M, Gabel MC, Asherson P, Baumeister S, Brandeis D, Hohmann S, Bramati IE, Tovar- Moll F, Fallgatter AJ, Kardatzki B, Schwarz L, Anikin A, Baranov A, Gogberashvili T, Kapilushniy D, Solovieva A, El Marroun H, White T, Karkashadze G, Namazova-Baranova L, Ethofer T, Mattos P, Banaschewski T, Coghill D, Plessen KJ, Kuntsi J, Mehta MA, Paloyelis Y, Harrison NA, Bellgrove MA, Silk TJ, Cubillo AI, Rubia K, Lazaro L, Brem S, Walitza S, Frodl T, Zentis M, Castellanos FX, Yoncheva YN, Haavik J, Reneman L, Conzelmann A, Lesch KP, Pauli P, Reif A, Tamm L, Konrad K, Oberwelland Weiss E, Busatto GF, Louza MR, Durston S, Hoekstra PJ, Oosterlaan J, Stevens MC, Ramos-Quiroga JA, Vilarroya O, Fair DA, Nigg JT, Thompson PM, Buitelaar JK, Faraone SV, Shaw P, Tiemeier H, Bralten J, Franke B. Brain Imaging of the Cortex in ADHD: A Coordinated Analysis of Large-Scale Clinical and Population-Based Samples. Am J Psychiatry 2019; 176(7):531-542. PMID: 31014101.

Boedhoe PSW, van Rooij D, Hoogman M, Twisk JWR, Schmaal L, Abe Y, Alonso P, Ameis SH, Anikin A, Anticevic A, Arango C, Arnold PD, Asherson P, Assogna F, Auzias G, Banaschewski T, Baranov A, Batistuzzo MC, Baumeister S, Baur-Streubel R, Behrmann M, Bellgrove MA, Benedetti F, Beucke JC, Biederman J, Bollettini I, Bose A, Bralten J, Bramati IE, Brandeis D, Brem S, Brennan BP, Busatto GF, Calderoni S, Calvo A, Calvo R, Castellanos FX, Cercignani M, Chaim-Avancini TM, Chantiluke KC, Cheng Y, Cho KIK, Christakou A, Coghill D, Conzelmann A, Cubillo AI, Dale AM, Dallaspezia S, Daly E, Denys D, Deruelle C, Di Martino A, Dinstein I, Doyle AE, Durston S, Earl EA, Ecker C, Ehrlich S, Ely BA, Epstein JN, Ethofer T, Fair DA, Fallgatter AJ, Faraone SV, Fedor J, Feng X, Feusner JD, Fitzgerald J, Fitzgerald KD, Fouche JP, Freitag CM, Fridgeirsson EA, Frodl T, Gabel MC, Gallagher L, Gogberashvili T, Gori I, Gruner P, Gürsel DA, Haar S, Haavik J, Hall GB, Harrison NA, Hartman CA, Heslenfeld DJ, Hirano Y, Hoekstra PJ, Hoexter MQ, Hohmann S, Høvik MF, Hu H, Huyser C, Jahanshad N, Jalbrzikowski M, James A, Janssen J, Jaspers-Fayer F, Jernigan TL, Kapilushniy D, Kardatzki B, Karkashadze G, Kathmann N, Kaufmann C, Kelly C, Khadka S, King JA, Koch K, Kohls G, Konrad K, Kuno M, Kuntsi J, Kvale G, Kwon JS, Lázaro L, Lera-Miguel S, Lesch KP, Hoekstra L, Liu Y, Lochner C, Louza MR, Luna B, Lundervold AJ, Malpas CB, Marques P, Marsh R, Martínez-Zalacaín I, Mataix-Cols D, Mattos P, McCarthy H, McGrath J, Mehta MA, Menchón JM, Mennes M, Martinho MM, Moreira PS, Morer A, Morgado P, Muratori F, Murphy CM, Murphy DGM, Nakagawa A, Nakamae T, Nakao T, Namazova-Baranova L, Narayanaswamy JC, Nicolau R, Nigg JT, Novotny SE, Nurmi EL, Weiss EO, O'Gorman Tuura RL, O'Hearn K, O'Neill J, Oosterlaan J, Oranje B, Paloyelis Y, Parellada M, Pauli P, Perriello C, Piacentini J, Piras F, Piras F, Plessen KJ, Puig O, Ramos-Quiroga JA, Reddy YCJ, Reif A, Reneman L, Retico A, Rosa PGP, Rubia K, Rus OG, Sakai Y, Schrantee A, Schwarz L, Schweren LJS, Seitz J, Shaw P, Shook D, Silk TJ, Simpson HB, Skokauskas N, Soliva Vila JC, Solovieva A, Soreni N, Soriano-Mas C, Spalletta G, Stern ER, Stevens MC, Stewart SE, Sudre G, Szeszko PR, Tamm L, Taylor MJ, Tolin DF, Tosetti M, Tovar-Moll F, Tsuchiyagaito A, van Erp TGM, van Wingen GA, Vance A, Venkatasubramanian G, Vilarroya O, Vives-Gilabert Y, von Polier GG, Walitza S, Wallace GL, Wang Z, Wolfers T, Yoncheva YN, Yun JY, Zanetti MV, Zhou F, Ziegler GC, Zierhut KC, Zwiers MP; ENIGMA ADHD working group; ENIGMA ASD working group; ENIGMA OCD working group, Thompson PM, Stein DJ, Buitelaar J, Franke B, van den Heuvel OA. Subcortical Brain Volume, Regional Cortical Thickness, and Cortical Surface Area Across Disorders: Findings From the ENIGMA ADHD, ASD, and OCD Working Groups. Am J Psychiatry. 2020 Sep 1;177(9):834-843. Epub 2020 Jun 16. Erratum in: Am J Psychiatry. 2020; 177(9):843. (Impact Factor: 18.112) PMID: 32539527.

Writing Committee for the Attention-Deficit/Hyperactivity Disorder; Autism Spectrum Disorder; Bipolar Disorder; Major Depressive Disorder; Obsessive- Compulsive Disorder; and Schizophrenia ENIGMA Working Groups, Patel Y, Parker N, Shin J, Howard D, French L, Thomopoulos SI, Pozzi E, Abe Y, Abé C, Anticevic A, Alda M, Aleman A, Alloza C, Alonso-Lana S, Ameis SH, Anagnostou E, McIntosh AA, Arango C, Arnold PD, Asherson P, Assogna F, Auzias G, Ayesa-Arriola R, Bakker G, Banaj N, Banaschewski T, Bandeira CE, Baranov A, Bargalló N, Bau CHD, Baumeister S, Baune BT, Bellgrove MA, Benedetti F, Bertolino A, Boedhoe PSW, Boks M, Bollettini I, Del Mar Bonnin C, Borgers T, Borgwardt S, Brandeis D, Brennan BP, Bruggemann JM, Bülow R, Busatto GF, Calderoni S, Calhoun VD, Calvo R, Canales- Rodríguez EJ, Cannon DM, Carr VJ, Cascella N, Cercignani M, Chaim-Avancini TM, Christakou A, Coghill D, Conzelmann A, Crespo-Facorro B, Cubillo AI, Cullen KR, Cupertino RB, Daly E, Dannlowski U, Davey CG, Denys D, Deruelle C, Di Giorgio A, Dickie EW, Dima D, Dohm K, Ehrlich S, Ely BA, Erwin-Grabner T, Ethofer T, Fair DA, Fallgatter AJ, Faraone SV, Fatjó-Vilas M, Fedor JM, Fitzgerald KD, Ford JM, Frodl T, Fu CHY, Fullerton JM, Gabel MC, Glahn DC, Roberts G, Gogberashvili T, Goikolea JM, Gotlib IH, Goya-Maldonado R, Grabe HJ, Green MJ, Grevet EH, Groenewold NA, Grotegerd D, Gruber O, Gruner P, Guerrero-Pedraza A, Gur RE, Gur RC, Haar S, Haarman BCM, Haavik J, Hahn T, Hajek T, Harrison BJ, Harrison NA, Hartman CA, Whalley HC, Heslenfeld DJ, Hibar DP, Hilland E, Hirano Y, Ho TC, Hoekstra PJ, Hoekstra L, Hohmann S, Hong LE, Höschl C, Høvik MF, Howells FM, Nenadic I, Jalbrzikowski M, James AC, Janssen J, Jaspers-Fayer F, Xu J, Jonassen R, Karkashadze G, King JA, Kircher T, Kirschner M, Koch K, Kochunov P, Kohls G, Konrad K, Krämer B, Krug A, Kuntsi J, Kwon JS, Landén M, Landrø NI, Lazaro L, Lebedeva IS, Leehr EJ, Lera-Miguel S, Lesch KP, Lochner C, Louza MR, Luna B, Lundervold AJ, MacMaster FP, Maglanoc LA, Malpas CB, Portella MJ, Marsh R, Martyn FM, Mataix-Cols D, Mathalon DH, McCarthy H, McDonald C, McPhilemy G, Meinert S, Menchón JM, Minuzzi L, Mitchell PB, Moreno C, Morgado P, Muratori F, Murphy CM, Murphy D, Mwangi B, Nabulsi L, Nakagawa A, Nakamae T, Namazova L, Narayanaswamy J, Jahanshad N, Nguyen DD, Nicolau R, O'Gorman Tuura RL, O'Hearn K, Oosterlaan J, Opel N, Ophoff RA, Oranje B, García de la Foz VO, Overs BJ, Paloyelis Y, Pantelis C, Parellada M, Pauli P, Picó-Pérez M, Picon FA, Piras F, Piras F, Plessen KJ, Pomarol-Clotet E, Preda A, Puig O, Quidé Y, Radua J, Ramos- Quiroga JA, Rasser PE, Rauer L, Reddy J, Redlich R, Reif A, Reneman L, Repple J, Retico A, Richarte V, Richter A, Rosa PGP, Rubia KK, Hashimoto R, Sacchet MD, Salvador R, Santonja J, Sarink K, Sarró S, Satterthwaite TD, Sawa A, Schall U, Schofield PR, Schrantee A, Seitz J, Serpa MH, Setién-Suero E, Shaw P, Shook D, Silk TJ, Sim K, Simon S, Simpson HB, Singh A, Skoch A, Skokauskas N, Soares JC, Soreni N, Soriano-Mas C, Spalletta G, Spaniel F, Lawrie SM, Stern ER, Stewart SE, Takayanagi Y, Temmingh HS, Tolin DF, Tomecek D, Tordesillas-Gutiérrez D, Tosetti M, Uhlmann A, van Amelsvoort T, van der Wee NJA, van der Werff SJA, van Haren NEM, van Wingen GA, Vance A, Vázquez-Bourgon J, Vecchio D, Venkatasubramanian G, Vieta E, Vilarroya O, Vives-Gilabert Y, Voineskos AN, Völzke H, von Polier GG, Walton E, Weickert TW, Weickert CS, Weideman AS, Wittfeld K, Wolf DH, Wu MJ, Yang TT, Yang K, Yoncheva Y, Yun JY, Cheng Y, Zanetti MV, Ziegler GC, Franke B, Hoogman M, Buitelaar JK, van Rooij D, Andreassen OA, Ching CRK, Veltman DJ, Schmaal L, Stein DJ, van den Heuvel OA, Turner JA, van Erp TGM, Pausova Z, Thompson PM, Paus T. Virtual Histology of Cortical Thickness and Shared Neurobiology in 6 Psychiatric Disorders. JAMA Psychiatry. 2021 Jan 1;78(1):47-63. Erratum in: JAMA Psychiatry. 2021; 78(1):112. (Impact Factor: 21.596) PMID: 32857118.

Calvo A, Roddy DW, Coughlan H, Kelleher I, Healy C, Harley M, Clarke M, Leemans A, Frodl T, O'Hanlon E, Cannon M. Reduced hippocampal volume in adolescents with psychotic experiences: A longitudinal population-based study. PLoS One. 2020; 15(6):e0233670. (Impact Factor: 3.240) PMID: 32492020.

Li T, van Rooij D, Roth Mota N, Buitelaar JK; ENIGMA ADHD Working Group, Hoogman M, Arias Vasquez A, Franke B. Characterizing neuroanatomic heterogeneity in people with and without ADHD based on subcortical brain volumes. J Child Psychol Psychiatry 2021; 62(9):1140-1149. (Impact Factor: 1.92) PMID: 33786843.

Psychotic experiences in childhood are associated with increased structural integrity of the left arcuate fasciculus – A population-based case-control study. Dooley N, O'Hanlon E, Healy C, Adair A, McCandless C, Coppinger D, Kelleher I, Clarke M, Leemans A, Frodl T, Cannon M. Schizophr Res. 2020;215:378-384. (Impact Factor: 4.569). PMID: 31495700.

Insulin-signaling abnormalities in drug-naïve first-episode schizophrenia: Transduction protein analyses in extracellular vesicles of putative neuronal origin. Kapogiannis D, Dobrowolny H, Tran J, Mustapic M, Frodl T, Meyer-Lotz G, Schiltz K, Schanze D, Rietschel M, Bernstein HG, Steiner J. Eur Psychiatry. 2019;62:124-129. (Impact Factor: 3.941). PMID: 31590015

Innate Immune Cells and C-Reactive Protein in Acute First-Episode Psychosis and Schizophrenia: Relationship to Psychopathology and Treatment. Steiner J, Frodl T, Schiltz K, Dobrowolny H, Jacobs R, Fernandes BS, Guest PC, Meyer-Lotz G, Borucki K, Bahn S, Bogerts B, Falkai P, Bernstein HG. Schizophr Bull. 2019. pii: sbz068. (Impact Factor: 7.289). PMID: 31504969.

White matter disturbances in major depressive disorder: a coordinated analysis across 20 international cohorts in the ENIGMA MDD working group. van Velzen LS, Kelly S, Isaev D, Aleman A, Aftanas LI, Bauer J, Baune BT, Brak IV, Carballedo A, Connolly CG, Couvy-Duchesne B, Cullen KR, Danilenko KV, Dannlowski U, Enneking V, Filimonova E, Förster K, Frodl T, Gotlib IH, Groenewold NA, Grotegerd D, Harris MA, Hatton SN, Hawkins EL, Hickie IB, Ho TC, Jansen A, Kircher T, Klimes-Dougan B, Kochunov P, Krug A, Lagopoulos J, Lee R, Lett TA, Li M, MacMaster FP, Martin NG, McIntosh AM, McLellan Q, Meinert S, Nenadić I, Osipov E, Penninx BWJH, Portella MJ, Repple J, Roos A, Sacchet MD, Sämann PG, Schnell K, Shen X, Sim K, Stein DJ, van Tol MJ, Tomyshev AS, Tozzi L, Veer IM, Vermeiren R, Vives-Gilabert Y, Walter H, Walter M, van der Wee NJA, van der Werff SJA, Schreiner MW, Whalley HC, Wright MJ, Yang TT, Zhu A, Veltman DJ, Thompson PM, Jahanshad N, Schmaal L. Mol Psychiatry. 2019. (epub ahead) (Impact Factor: 11.973). PMID: 31471575.

No Alterations of Brain Structural Asymmetry in Major Depressive Disorder: An ENIGMA Consortium Analysis. de Kovel CGF, Aftanas L, Aleman A, Alexander-Bloch AF, Baune BT, Brack I, Bülow R, Busatto Filho G, Carballedo A, Connolly CG, Cullen KR, Dannlowski U, Davey CG, Dima D, Dohm K, Erwin-Grabner T, Frodl T, Fu CHY, Hall GB, Glahn DC, Godlewska B, Gotlib IH, Goya-Maldonado R, Grabe HJ, Groenewold NA, Grotegerd D, Gruber O, Harris MA, Harrison BJ, Hatton SN, Hickie IB, Ho TC, Jahanshad N, Kircher T, Krämer B, Krug A, Lagopoulos J, Leehr EJ, Li M, MacMaster FP, MacQueen G, McIntosh AM, McLellan Q, Medland SE, Mueller BA, Nenadic I, Osipov E, Papmeyer M, Portella MJ, Reneman L, Rosa PGP, Sacchet MD, Schnell K, Schrantee A, Sim K, Simulionyte E, Sindermann L, Singh A, Stein DJ, Ubani BN, Van der Wee NJA, Van der Werff SJA, Veer IM, Vives-Gilabert Y, Völzke H, Walter H, Walter M, Schreiner MW, Whalley H, Winter N, Wittfeld K, Yang TT, Yüksel D, Zaremba D, Thompson PM, Veltman DJ, Schmaal L, Francks C. Am J Psychiatry. 2019;176(12):1039-1049. (Impact Factor: 13.655). PMID: 31352813

10Kin1day: A Bottom-Up Neuroimaging Initiative. van den Heuvel MP, Scholtens LH, van der Burgh HK, Agosta F, Alloza C, Arango C, Auyeung B, Baron-Cohen S, Basaia S, Benders MJNL, Beyer F, Booij L, Braun KPJ, Filho GB, Cahn W, Cannon DM, Chaim-Avancini TM, Chan SSM, Chen EYH, Crespo-Facorro B, Crone EA, Dannlowski U, de Zwarte SMC, Dietsche B, Donohoe G, Plessis SD, Durston S, Díaz-Caneja CM, Díaz-Zuluaga AM, Emsley R, Filippi M, Frodl T, Gorges M, Graff B, Grotegerd D, Gąsecki D, Hall JM, Holleran L, Holt R, Hopman HJ, Jansen A, Janssen J, Jodzio K, Jäncke L, Kaleda VG, Kassubek J, Masouleh SK, Kircher T, Koevoets MGJC, Kostic VS, Krug A, Lawrie SM, Lebedeva IS, Lee EHM, Lett TA, Lewis SJG, Liem F, Lombardo MV, Lopez-Jaramillo C, Margulies DS, Markett S, Marques P, Martínez-Zalacaín I, McDonald C, McIntosh AM, McPhilemy G, Meinert SL, Menchón JM, Montag C, Moreira PS, Morgado P, Mothersill DO, Mérillat S, Müller HP, Nabulsi L, Najt P, Narkiewicz K, Naumczyk P, Oranje B, Ortiz-Garcia de la Foz V, Peper JS, Pineda JA, Rasser PE, Redlich R, Repple J, Reuter M, Rosa PGP, Ruigrok ANV, Sabisz A, Schall U, Seedat S, Serpa MH, Skouras S, Soriano-Mas C, Sousa N, Szurowska E, Tomyshev AS, Tordesillas-Gutierrez D, Valk SL, van den Berg LH, van Erp TGM, van Haren NEM, van Leeuwen JMC, Villringer A, Vinkers CH, Vollmar C, Waller L, Walter H, Whalley HC, Witkowska M, Witte AV, Zanetti MV, Zhang R, de Lange SC. Front Neurol. 2019;10:425. (Impact Factor: 2.635). PMID: 31133958

Brain Imaging of the Cortex in ADHD: A Coordinated Analysis of Large-Scale Clinical and Population-Based Samples. Hoogman M, Muetzel R, Guimaraes JP, Shumskaya E, Mennes M, Zwiers MP, Jahanshad N, Sudre G, Wolfers T, Earl EA, Soliva Vila JC, Vives-Gilabert Y, Khadka S, Novotny SE, Hartman CA, Heslenfeld DJ, Schweren LJS, Ambrosino S, Oranje B, de Zeeuw P, Chaim-Avancini TM, Rosa PGP, Zanetti MV, Malpas CB, Kohls G, von Polier GG, Seitz J, Biederman J, Doyle AE, Dale AM, van Erp TGM, Epstein JN, Jernigan TL, Baur-Streubel R, Ziegler GC, Zierhut KC, Schrantee A, Høvik MF, Lundervold AJ, Kelly C, McCarthy H, Skokauskas N, O'Gorman Tuura RL, Calvo A, Lera-Miguel S, Nicolau R, Chantiluke KC, Christakou A, Vance A, Cercignani M, Gabel MC, Asherson P, Baumeister S, Brandeis D, Hohmann S, Bramati IE, Tovar-Moll F, Fallgatter AJ, Kardatzki B, Schwarz L, Anikin A, Baranov A, Gogberashvili T, Kapilushniy D, Solovieva A, El Marroun H, White T, Karkashadze G, Namazova-Baranova L, Ethofer T, Mattos P, Banaschewski T, Coghill D, Plessen KJ, Kuntsi J, Mehta MA, Paloyelis Y, Harrison NA, Bellgrove MA, Silk TJ, Cubillo AI, Rubia K, Lazaro L, Brem S, Walitza S, Frodl T, Zentis M, Castellanos FX, Yoncheva YN, Haavik J, Reneman L, Conzelmann A, Lesch KP, Pauli P, Reif A, Tamm L, Konrad K, Oberwelland Weiss E, Busatto GF, Louza MR, Durston S, Hoekstra PJ, Oosterlaan J, Stevens MC, Ramos-Quiroga JA, Vilarroya O, Fair DA, Nigg JT, Thompson PM, Buitelaar JK, Faraone SV, Shaw P, Tiemeier H, Bralten J, Franke B. Am J Psychiatry. 2019;176(7):531-542. (Impact Factor: 13.655). PMID: 31014101

Neurobiological correlates of violence perception in martial artists. Schöne M, Seidenbecher S, Tozzi L, Kaufmann J, Griep H, Fenker D, Frodl T, Bogerts B, Schiltz K. Brain Behav. 2019;9(5):e01276. (Impact Factor: 2.072). PMID: 30907076

The Hippocampus in Depression: More Than the Sum of Its Parts? Advanced Hippocampal Substructure Segmentation in Depression. Roddy DW, Farrell C, Doolin K, Roman E, Tozzi L, Frodl T, O'Keane V, O'Hanlon E. Biol Psychiatry. 2019 Mar 15;85(6):487-497. (Impact Factor: 11.984) PMID: 30528746

Reduced volumes of the external and internal globus pallidus in male heroin addicts: a postmortem study. Müller UJ, Mawrin C, Frodl T, Dobrowolny H, Busse S, Bernstein HG, Bogerts B, Truebner K, Steiner J. Eur Arch Psychiatry Clin Neurosci. 2019;269(3):317-324. (Impact Factor: 3.614) PMID: 30173319

*Mapping cortical brain asymmetry in 17,141 healthy individuals worldwide via the ENIGMA Consortium. Kong XZ, Mathias SR, Guadalupe T, Abé C, Agartz I, Akudjedu TN, Aleman A, Alhusaini S, Allen NB, Ames D, Andreassen OA, Vasquez AA,Armstrong NJ, Bergo F, Bastin ME, Batalla A, Bauer J, Baune BT, Baur-Streubel R, Biederman J, Blaine SK, Boedhoe P, Bøen E, Bose A, Bralten J, Brandeis D, Brem S, Brodaty H, Yüksel D, Brooks SJ, Buitelaar J, Bürger C, Bülow R, Calhoun V, Calvo A, Canales-Rodríguez EJ, Canive JM,Cannon DM, Caparelli EC, Castellanos FX, Cavalleri GL, Cendes F, Chaim-Avancini TM, Chantiluke K, Chen QL, Chen X, Cheng Y, Christakou A,Clark VP, Coghill D, Connolly CG, Conzelmann A, Córdova-Palomera A, Cousijn J, Crow T, Cubillo A, Dale A, Dannlowski U, Ambrosino de Bruttopilo S, de Zeeuw P, Deary IJ, Delanty N, Demeter DV, Di Martino A, Dickie EW, Dietsche B, Doan NT, Doherty CP, Doyle A, Durston S, Earl E, Ehrlich S, Ekman CJ, Elvsåshagen T, Epstein JN, Fair DA, Faraone SV, Fernández G, Filho GB, Förster K, Fouche JP, Foxe JJ, Frodl T,Fuentes-Claramonte P, Fullerton J, Garavan H, Garcia DDS, Gotlib IH, Goudriaan AE, Grabe HJ, Groenewold NA, Grotegerd D, Gruber O, Gurholt T, Haavik J, Hahn T, Hansell NK, Harris MA, Hartman CA, Hernández MDCV, Heslenfeld D, Hester R, Hibar DP, Ho BC, Ho TC, Hoekstra PJ, van Holst RJ, Hoogman M, Høvik MF, Howells FM, Hugdahl K, Huyser C, Ingvar M, Irwin L, Ishikawa A, James A, Jahanshad N, Jernigan TL, Jönsson EG, Kähler C, Kaleda V, Kelly C, Kerich M, Keshavan MS, Khadka S, Kircher T, Kohls G, Konrad K, Korucuoglu O, Krämer B, Krug A, Kwon JS,Lambregts-Rommelse N, Landén M, Lázaro L, Lebedeva I, Lenroot R, Lesch KP, Li Q, Lim KO, Liu J, Lochner C, London ED, Lonning V,Lorenzetti V, Luciano M, Luijten M, Lundervold AJ, Mackey S, MacMaster FP, Maingault S, Malpas CB, Malt UF, Mataix-Cols D, Martin-Santos R,Mayer AR, McCarthy H, Mitchell PB, Mueller BA, Maniega SM, Mazoyer B, McDonald C, McLellan Q, McMahon KL, McPhilemy G, Momenan R,Morales AM, Narayanaswamy JC, Moreira JCV, Nerland S, Nestor L, Newman E, Nigg JT, Nordvik JE, Novotny S, Weiss EO, O'Gorman RL,Oosterlaan J, Oranje B, Orr C, Overs B, Pauli P, Paulus M, Plessen KJ, von Polier GG, Pomarol-Clotet E, Portella MJ, Qiu J, Radua J, Ramos-Quiroga JA, Reddy YCJ, Reif A, Roberts G, Rosa P, Rubia K, Sacchet MD, Sachdev PS, Salvador R, Schmaal L, Schulte-Rüther M, Schweren L,Seidman L, Seitz J, Serpa MH, Shaw P, Shumskaya E, Silk TJ, Simmons AN, Simulionyte E, Sinha R, Sjoerds Z, Smelror RE, Soliva JC, Solowij N, Souza-Duran FL, Sponheim SR, Stein DJ, Stein EA, Stevens M, Strike LT, Sudre G, Sui J, Tamm L, Temmingh HS, Thoma RJ, Tomyshev A,Tronchin G, Turner J, Uhlmann A, van Erp TGM, van den Heuvel OA, van der Meer D, van Eijk L, Vance A, Veer IM, Veltman DJ,Venkatasubramanian G, Vilarroya O, Vives-Gilabert Y, Voineskos AN, Völzke H, Vuletic D, Walitza S, Walter H, Walton E, Wardlaw JM, Wen W,Westlye LT, Whelan CD, White T, Wiers RW, Wright MJ, Wittfeld K, Yang TT, Yasuda CL, Yoncheva Y, Yücel M, Yun JY, Zanetti MV, Zhen Z, Zhu XX, Ziegler GC, Zierhut K, de Zubicaray GI, Zwiers M, Glahn DC, Franke B, Crivello F, Tzourio-Mazoyer N, Fisher SE, Thompson PM, Francks C,Farde L, Flyckt L, Engberg G, Erhardt S, Fatouros-Bergman H, Cervenka S, Schwieler L, Piehl F, Agartz I, Collste K, Victorsson P, Malmqvist A,Hedberg M, Orhan F., Glahn DC2,4, Franke B5,6, Crivello F7, Tzourio-Mazoyer N7, Fisher SE3,8,Thompson PM9, Francks C1,8. Proc Natl Acad Sci U S A. 2018;115(22):E5154-E5163. (Impact Factor: 9.504).

Aggressiveness of martial artists correlates with reduced temporal pole grey matter concentration. Breitschuh S, Schöne M, Tozzi L, Kaufmann J, Strumpf H, Fenker D, Frodl T, Bogerts B, Schiltz K. Psychiatry Res Neuroimaging. 2018;281:24-30. (Impact Factor: 2.455). PMID: 30216861

Awakening Neuropsychiatric Research Into the Stria Medullaris: Development of a Diffusion-Weighted Imaging Tractography Protocol of This Key Limbic Structure. Roddy DW, Roman E, Rooney S, Andrews S, Farrell C, Doolin K, Levins KJ, Tozzi L, Tierney P, Barry D, Frodl T, O'Keane V, O'Hanlon E. Front Neuroanat. 2018;12:39. (Impact Factor: 3.152) PMID: 29867378

DNA methylation differences at the glucocorticoid receptor gene in depression are related to functional alterations in hypothalamic-pituitary-adrenal axis activity and to early life emotional abuse. Farrell C, Doolin K, O' Leary N, Jairaj C, Roddy D, Tozzi L, Morris D, Harkin A, Frodl T, Nemoda Z, Szyf M, Booij L, O'Keane V. Psychiatry Res. 2018;265:341-348. (Impact Factor: 2.223) PMID: 29793048

Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes. Doolin K, Allers KA, Pleiner S, Liesener A, Farrell C, Tozzi L, O'Hanlon E, Roddy D, Frodl T, Harkin A, O'Keane V. Psychoneuroendocrinology. 2018;95:8-17. (Impact Factor: 4.731) PMID: 29787958

Total hypothalamic volume is reduced in postmortem brains of male heroin addicts. Müller UJ, Schiltz K, Mawrin C, Dobrowolny H, Frodl T, Bernstein HG, Bogerts B, Truebner K, Steiner J. Eur Arch Psychiatry Clin Neurosci. 2018; 268(3):243-248. (Impact Factor: 3.614) PMID: 28534187

Increased quinolinic acid in peripheral mononuclear cells in Alzheimer's dementia. Busse M, Hettler V, Fischer V, Mawrin C, Hartig R, Dobrowolny H, Bogerts B, Frodl T, Busse S. Eur Arch Psychiatry Clin Neurosci. 2018; 268(5):493-500. (Impact Factor: 3.614) PMID: 28386767

Machine learning classification of first-episode schizophrenia spectrum disorders and controls using whole brain white matter fractional anisotropy. Mikolas P, Hlinka J, Skoch A, Pitra Z, Frodl T, Spaniel F, Hajek T. BMC Psychiatry. 2018;18(1):97. (Impact Factor: 2.419) PMID: 29636016

Dysfunction of the blood-cerebrospinal fluid-barrier and N-methyl-D-aspartate glutamate receptor antibodies in dementias. Busse M, Kunschmann R, Dobrowolny H, Hoffmann J, Bogerts B, Steiner J, Frodl T, Busse S. Eur Arch Psychiatry Clin Neurosci. 2018;268(5):483-492. (Impact Factor: 3.614) PMID: 28176002.

Brain stimulation-induced neuroplasticity underlying therapeutic response in phantom sounds. Poeppl TB, Langguth B, Lehner A, Frodl T, Rupprecht R, Kreuzer PM, Landgrebe M, Schecklmann M. Hum Brain Mapp. 2018;39(1):554-562. (Impact Factor: 4.927) PMID: 29064602.

Diurnal Hypothalamic-Pituitary-Adrenal Axis Measures and Inflammatory Marker Correlates in Major Depressive Disorder. Doolin K, Farrell C, Tozzi L, Harkin A, Frodl T, O'Keane V. Int J Mol Sci. 2017;18(10):Pii E2226. (Impact Factor: 3.687) PMID: 29064428

Alterations in the Peripheral Immune System in Dementia. Busse M, Michler E, von Hoff F, Dobrowolny H, Hartig R, Frodl T, Busse S. J Alzheimers Dis. 2017;58(4):1303-1313. (Impact Factor: 3.476) PMID: 28582858

Psychotic Symptoms Associated with Poor Renal Function in Mild Cognitiv Impairment and Dementias. Kunschmann R, Busse S, Frodl T, Busse M. J Alzheimers Dis. 2017;58(1):243-252. (Impact Factor: 3.476) PMID: 28387674

Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults: a cross-sectional mega-analysis. Hoogman M, Bralten J, Hibar DP, Mennes M, Zwiers MP, Schweren LSJ, van Hulzen KJE, Medland SE, Shumskaya E, Jahanshad N, Zeeuw P, Szekely E, Sudre G, Wolfers T, Onnink AMH, Dammers JT, Mostert JC, Vives-Gilabert Y, Kohls G, Oberwelland E, Seitz J, Schulte-Rüther M, Ambrosino S, Doyle AE, Høvik MF, Dramsdahl M, Tamm L, van Erp TGM, Dale A, Schork A, Conzelmann A, Zierhut K, Baur R, McCarthy H, Yoncheva YN, Cubillo A, Chantiluke K, Mehta MA, Paloyelis Y, Hohmann S, Baumeister S, Bramati I, Mattos P, Tovar-Moll F, Douglas P, Banaschewski T, Brandeis D, Kuntsi J, Asherson P, Rubia K, Kelly C, Martino AD, Milham MP, Castellanos FX, Frodl T, Zentis M, Lesch KP, Reif A, Pauli P, Jernigan TL, Haavik J, Plessen KJ, Lundervold AJ, Hugdahl K, Seidman LJ, Biederman J, Rommelse N, Heslenfeld DJ, Hartman CA, Hoekstra PJ, Oosterlaan J, Polier GV, Konrad K, Vilarroya O, Ramos-Quiroga JA, Soliva JC, Durston S, Buitelaar JK, Faraone SV, Shaw P, Thompson PM, Franke B. Lancet Psychiatry. 2017;4(4):310-319. (Impact Factor: 15.233) PMID: 28219628.

Functional Connectivity Anomalies in Adolescents with Psychotic Symptoms. Amico F, O'Hanlon E, Kraft D, Oertel-Knöchel V, Clarke M, Kelleher I, Higgins N, Coughlan H, Creegan D, Heneghan M, Power E, Power L, Ryan J, Frodl T, Cannon M. PLoS One. 2017 26;12(1):e0169364. eCollection (Impact Factor: 2.776) PMID: 28125578

Oxidative stress in drug-naïve first episode patients with schizophrenia and major depression: effects of disease acuity and potential confounders. Jordan W, Dobrowolny H, Bahn S, Bernstein HG, Brigadski T, Frodl T, Isermann B, Lessmann V, Pilz J, Rodenbeck A, Schiltz K, Schwedhelm E, Tumani H, Wiltfang J, Guest PC, Steiner J. Eur Arch Psychiatry Clin Neurosci. 2018; 268:129-143. (Impact Factor: 3.614) PMID: 27913877

Further evidence of alerted default network connectivity and association with theory of mind ability in schizophrenia. Mothersill O, Tangney N, Morris DW, McCarthy H, Frodl T, Gill M, Corvin A, Donohoe G. Schizophr Res. 2017 184:52-58. (Impact Factor: 3.958) PMID: 27913157

Progressive white matter impairment as a predictor of outcome in a cohort of opioid-dependent patient's post-detoxification. Ivers JH, Fitzgerald J, Whelan C, Sweeney B, Keenan E, Fagan A, McMarrow J, Meany J, Barry J, Frodl T. Addict Biol. 2018;23(1):304-312. (Impact Factor: 5.578) PMID: 27739172

Testosterone causes both prosocial and antisocial status-enhancing behaviors in human males. Dreher JC, Dunne S, Pazderska A, Frodl T, Nolan JJ, O'Doherty JP. Proc Natl Acad Sci U S A. 2016;113(41):11633-11638. (Imact Factor: 9.504) PMID: 27671627

Common and distinct patterns of grey-matter volume alteration in major depression and bipolar disorder: evidence from voxel-based meta-analysis. Wise T, Radua J, Via E, Cardoner N, Abe O, Adams TM, Amico F, Cheng Y, Cole JH, de Azevedo Marques Périco C, Dickstein DP, Farrow TFD, Frodl T, Wagner G, Gotlib IH, Gruber O, Ham BJ, Job DE, Kempton MJ, Kim MJ, Koolschijn PCMP, Malhi GS, Mataix-Cols D, McIntosh AM, Nugent AC, O'Brien JT, Pezzoli S, Phillips ML, Sachdev PS, Salvadore G, Selvaraj S, Stanfield AC, Thomas AJ, van Tol MJ, van der Wee NJA, Veltman DJ, Young AH, Fu CH, Cleare AJ, Arnone D. Mol Psychiatry. 2017;22(10):1455-1463. (Impact Factor: 11.640) PMID: 27217146

Nucleus Accumbens Deep Brain Stimulation for Alcohol Addiction - Safety and Clinical Long-term Results of a Pilot Trial. Müller UJ, Sturm V, Voges J, Heinze HJ, Galazky I, Büntjen L, Heldmann M, Frodl T, Steiner J, Bogerts B. Pharmacopsychiatry. 2016; 49(4):170-173. (Impact Factor: 2.064) PMID: 27145161

Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working Group. Schmaal L, Hibar DP, Sämann PG, Hall GB, Baune BT, Jahanshad N, Cheung JW, van Erp TGM, Bos D, Ikram MA, Vernooij MW, Niessen WJ, Tiemeier H, Hofman A, Wittfeld K, Grabe HJ, Janowitz D, Bülow R, Selonke M, Völzke H, Grotegerd D, Dannlowski U, Arolt V, Opel N, Heindel W, Kugel H, Hoehn D, Czisch M, Couvy-Duchesne B, Rentería ME, Strike LT, Wright MJ, Mills NT, de Zubicaray GI, McMahon KL, Medland SE, Martin NG, Gillespie NA, Goya-Maldonado R, Gruber O, Krämer B, Hatton SN, Lagopoulos J, Hickie IB, Frodl T, Carballedo A, Frey EM, van Velzen LS, Penninx BWJH, van Tol MJ, van der Wee NJ, Davey CG, Harrison BJ, Mwangi B, Cao B, Soares JC, Veer IM, Walter H, Schoepf D, Zurowski B, Konrad C, Schramm E, Normann C, Schnell K, Sacchet MD, Gotlib IH, MacQueen GM, Godlewska BR, Nickson T, McIntosh AM, Papmeyer M, Whalley HC, Hall J, Sussmann JE, Li M, Walter M, Aftanas L, Brack I, Bokhan NA, Thompson PM, Veltman DJ. Mol Psychiatry. 2017;22(6):900-909. (Impact Factor: 11.640) PMID: 27137745

Heritability and reliability of automatically segmented human hippocampal formation subregions. Whelan CD, Hibar DP, van Velzen LS, Zannas AS, Carrillo-Roa T, McMahon K, Prasad G, Kelly S, Faskowitz J, deZubiracay G, Iglesias JE, van Erp TGM, Frodl T, Martin NG, Wright MJ, Jahanshad N, Schmaal L, Sämann PG, Thompson PM. Alzheimer's Disease Neuroimaging Initiative. Neuroimage. 2016;128:125-137. (Impact Factor: 5.426) PMID: 2674774

Assessment of Pharmacological Treatment Quality: Comparison of Symptom triggered vs. Fixed-schedule Alcohol Withdrawal in Clinical Practice. Müller UJ, Schuermann F, Dobrowolny H, Frodl T, Bogerts B, Mohr S, Steiner J. Pharmacopsychiatry. 2016;49(5):199-203. (Impact Factor: 2.064) PMID: 27101233

Reduced oxytocin receptor gene expression and binding sites in different brain regions in schizophrenia: A post-mortem study. Uhrig S, Hirth N, Broccoli L, von Wilmsdorff M, Bauer M, Sommer C, Zink M, Steiner J, Frodl T, Malchow B, Falkai P, Spanagel R, Hansson AC, Schmitt A. Schizophr Res. 2016;177(1-3):59-66. (Impact Factor: 3.958) PMID: 27132494

Computational meta-analysis of statistical parametric maps in major depression. Arnone D, Job D, Selvaraj S, Abe O, Amico F, Cheng Y, Colloby SJ, O'Brien JT, Frodl T, Gotlib IH, Ham BJ, Kim MJ, Koolschijn PC, Périco CA, Salvadore G, Thomas AJ, Van Tol MJ, van der Wee NJ, Veltman DJ, Wagner G, McIntosh AM. Hum Brain Mapp 2016;37(4):1393-404. (Impact Factor: 4.927) PMID: 26854015.

Assessment of competence in surgical skills using functional magnetic resonance imaging: a feasibility study. Morris MC, Frodl T, D'Souza A, Fagan AJ, Ridgway PF. J Surg Educ. 2015;72(2):198-204. (Impact Factor: 2.302).

Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group. Schmaal L, Veltman DJ, van Erp TG, Sämann PG, Frodl T, Jahanshad N, Loehrer E, Tiemeier H, Hofman A, Niessen WJ, Vernooij MW, Ikram MA, Wittfeld K, Grabe HJ, Block A, Hegenscheid K, Völzke H, Hoehn D, Czisch M, Lagopoulos J, Hatton SN, Hickie IB, Goya-Maldonado R, Krämer B, Gruber O, Couvy-Duchesne B, Rentería ME, Strike LT, Mills NT, de Zubicaray GI, McMahon KL, Medland SE, Martin NG, Gillespie NA, Wright MJ, Hall GB, MacQueen GM, Frey EM, Carballedo A, van Velzen LS, van Tol MJ, van der Wee NJ, Veer IM, Walter H, Schnell K, Schramm E, Normann C, Schoepf D, Konrad C, Zurowski B, Nickson T, McIntosh AM, Papmeyer M, Whalley HC, Sussmann JE, Godlewska BR, Cowen PJ, Fischer FH, Rose M, Penninx BW, Thompson PM, Hibar DP. Mol Psychiatry. 2016;21(6):806-12. (Impact Factor: 13.204) PMID: 26122586

White matter differences among adolescents reporting psychotic experiences. A population-based diffusion MRI study. O’Hanlon E, Leemans A, Kelleher I, Clarke M, Roddy S, Harley M, Amico F, Hoscheit M, Tiedt L, Tabish J, McGettigan A, Frodl T, Cannon M. JAMA Psychiatry. 2015;72(7):668-77. (Impact Factor: 16.642) PMID: 25923212

Individualized differential diagnosis of schizophrenia and mood disorders using neuroanatomical biomarkers. Koutsouleris N, Meisenzahl EM, Borgwardt S, Riecher-Rössler A, Frodl T, Kambeitz J, Köhler Y, Falkai P, Möller H-J, Reiser M, Davatzikos C. Brain. 2015;138(Pt 7):2059-2073. (Impact Factor: 10.848) PMID: 25935725

Accelerated Brain Aging in Schizophrenia and Beyond: A Neuroanatomical Marker of Psychiatric Disorders. Koutsouleris N, Davatzikos C, Borgwardt S, Gaser C, Bottlender R, Frodl T, Falkai P, Riecher-Rössler A, Möller HJ, Reiser M, Pantelis C, Meisenzahl E. Schizophr Bulletin. 2014;40(5):1140-1153. (Impact Factor: 7.575). PMID: 24126515

Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation. Hughes MM, Carballedo A, McLoughlin DM, Amico F, Harkin A, Frodl T, Connor TJ. Brain Behav Immun. 2012;26:979-987. (Impact Factor: 5.964) PMID: 22683764

Sex Modulates the Interactive Effect of the Serotonin Transporter Gene Polymorphism and Childhood Adversity on Hippocampal Volume. Everaerd D, Gerritsen L, Rijpkema M, Frodl T, van Oostrom I, Franke B, Fernández G, Tendolkar I. Neuropsychopharmacology. 2012; 37(8):1848-1855. (Impact Factor: 6.347) PMID: 22434222

The NOS1 variant rs6490121 is associated with variation in prefrontal function and grey matter density in healthy individuals. Rose EJ, Greene C, Kelly S, Morris DW, Robertson IH, Fahey C, Jacobson S, O'Doherty J, Newell FN, McGrath J, Bokde A, Garavan H, Frodl T, Gill M, Corvin AP, Donohoe G. Neuroimage. 2012; 60:614-622. (Impact Factor: 5.835) PMID: 22227051

Dual-isotope SPECT imaging of striatal dopamine: a comparative study between never-treated and haloperidol-treated first-episode schizophrenic patients. Schmitt GJ, Dresel S, Frodl T, la Fougère C, Boerner R, Hahn K, Möller HJ, Meisenzahl EM. Eur Arch Psychiatry Clin Neurosci. 2012;262(3):183-191. (Impact Factor: 3.569) PMID: 22081145

Disentangling the adult attention-deficit hyperactivity disorder endophenotype: Parametric measurement of attention. Finke K, Schwarzkopf W, Müller U, Frodl T, Müller HJ, Schneider WX, Engel RR, Riedel M, Möller HJ, Hennig-Fast K. J Abnorm Psychol. 2011;120(4):890-901. (Impact Factor: 4.133) PMID: 21859167

ZNF804A risk allele is associated with relatively intact gray matter volume in patients with schizophrenia. Donohoe G, Rose E, Frodl T, Morris D, Spoletini I, Adriano F, Bernardini S, Caltagirone C, Bossù P, Gill M, Corvin AP, Spalletta G. Neuroimage. 2011;54:2132-2137. (Impact Factor: 5.835) PMID: 20934520

Is evaluation of humorous stimuli associated with frontal cortex morphology? A pilot study using facial micro-movement analysis and MRI. Juckel G, Mergl R, Brüne M, Villeneuve I, Frodl T, Schmitt G, Zetzsche T, Born C, Hahn K, Reiser M, Möller HJ, Bär KJ, Hegerl U, Meisenzahl EM. Cortex. 2011;47:569-74. (Impact Factor: 4.729). PMID: 20537620

Anterior cingulum volumetry, auditory P300 in schizophrenia with negative symptoms. Preuss UW, Zetzsche T, Pogarell O, Mulert C, Frodl T, Müller D, Schmidt G, Born C, Reiser M, Möller HJ, Hegerl U, Meisenzahl EM. Psychiatry Res. 2010;183:133-139. (Impact Factor: 2.528) PMID: 20630714

Altered Brain Activation During a Verbal Working Memory Task in Subjects with Amnestic Mild Cognitive Impairment. Bokde AL, Karmann M, Born C, Teipel SJ, Omerovic M, Ewers M, Frodl T, Meisenzahl E, Reiser M, Möller HJ, Hampel H. J Alzheimers Dis.2010;21:103-118. (Impact Factor: 3.731) PMID: 20413893

Reduced occipital and pre-frontal brain volumes in Dysbindin associated schizophrenia. Donohoe G, Frodl T, Morris D, Spoletini I, Cannon DM, Cherubini A, Caltagirone C, Bossù P, McDonald C, Gill M, Corvin AP, Spalletta G. Neuropsychopharmacology. 2010; 35(2):368-373. (Impact Factor: 6.347) PMID: 19794403

Differences in hippocampal volume between major depression and schizophrenia: a comparative neuroimaging study. Meisenzahl EM, Seifert D, Bottlender R, Teipel S, Zetzsche T, Jäger M, Koutsouleris N, Schmitt G, Scheuerecker J, Burgermeister B, Hampel H, Rupprecht T, Born C, Reiser M, Möller HJ, Frodl T. Eur Arch Psychiatry Clin Neurosci.2010;260(2):127-137. (Impact Factor: 3.569) PMID: 19488671

 Increase of striatal dopamine transmission in first episode drug-naive schizophrenic patients as demonstrated by [(123)I]IBZM SPECT. Schmitt GJ, Meisenzahl EM, Frodl T, La Fougère C, Hahn K, Möller HJ, Dresel S. Psychiatry Res. 2009;30:173:183-189. (Impact Factor: 2.528) PMID:19683898

Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transition. Koutsouleris N, Meisenzahl EM, Davatzikos C, Bottlender R, Frodl T, Scheuerecker J, Schmitt G, Zetzsche T, Decker P, Reiser M, Möller HJ, Gaser C. Arch Gen Psychiatry. 2009;66:700-712. (Impact Factor: 15.307) PMID:19581561

5-HT_1A receptor gene C-1019 G polymorphism and amygdala volume in borderline personality disorder. Zetzsche T, Preuss UW, Bondy B, Frodl T, Zill P, Schmitt G, Koutsouleris N, Rujescu D, Born C, Reiser M, Möller H-J, Meisenzahl EM. Genes, Brain and Behavior. 2008;7:306-313. (Impact Factor: 3.743) PMID:18387137

Loudness dependence of the auditory evoked N1/P2-component as an indicator of serotonergic dysfunction in patients with schizophrenia – a replication study. Juckel G, Gudlowski Y, Müller D, Özgürdal S, Brüne M, Gallinat J, Frodl T, Witthaus H, Uhl I, Wutzler A, Pogarell O, Mulert C, Hegerl U, Meisenzahl E-M. Psychiatry Research. 2008;68:1206-1212. (Impact Factor: 2.528) PMID:18096246

Structural endophenotypes of psychopathological syndromes in schizophrenia: a voxel-based morphometry study. Koutsouleris N, Gaser C, Jäger M, Bottlender R, Frodl T, Holzinger S, Schmitt GJE, Zetzsche T, Borski I, Nenadic I, Burgermeister B, Scheuerecker J, Born C, Reiser M, Möller H-J, Meisenzahl E. Neuroimage. 2008;39:1600-1612. (Impact Factor: 5.835) PMID:18054834

Dual-isotope SPECT imaging of striatal dopamine: First episode, drug naïve schizophrenic patients. Schmitt GJ, la Fougère C, Dresel S, Frodl T, Hahn K, Möller HJ, Meisenzahl EM. Schizophr Res. 2008;101:133-141. (Impact Factor: 3.986) PMID:18083348

White matter alterations in schizophrenic patients with pronounced negative symptomatology and with positive family history for schizophrenia. Zetzsche T, Preuss UW, Frodl T, Leinsinger G, Born C, Reiser M, Hegerl U, Möller HJ, Meisenzahl EM. Eur Arch Psychiatry Clin Neurosci. 2008;258:278-284. (Impact Factor: 3.569) PMID:18437282

Diagnostic Usefulness of Cognitive Auditory Event-Related P300 Subcomponents in Patients with Alzheimers Disease? Juckel G, Clotz F, Frodl T, Kawohl W, Hampel H, Pogarell O, Hegerl U. J Clin Neurophysiol. 2008;25:147-152. (Impact Factor: 1.337) PMID:18469731

A case of persistent retrograde amnesia following a dissociative fugue: Neuropsychological and neurofunctional underpinnings of loss of autobiographical memory and self-awareness. Hennig-Fast K, Meister F, Frodl T, Beraldi A, Padberg F, Engel RR, Reiser M, Möller HJ, Meindl T. Neuropsychologia. 2008;46:2993-3005. (Impact Factor: 3.197) PMID: 18619985

Structural brain alterations at different stages of schizophrenia: A voxel-based morphometric study. Meisenzahl EM, Koutsouleris N, Bottlender R, Scheuerecker J, Jäger M, Teipel SJ, Holzinger S, Frodl T, Preuss U, Schmitt G, Burgermeister B, Reiser M, Born C, Möller HJ. Schizophr Res. 2008;104:44-60. (Impact Factor: 3.986) PMID: 18703313

Striatal D2/D3 Receptor Occupancy, Clinical Response and Side Effects with Amisulpride: An Iodine-123-Iodobenzamide SPET Study. Meisenzahl EM, Schmitt G, Gründer G, Dresel S, Frodl T, la Fougère C, Scheuerecker J, Schwarz M, Boerner R, Stauss J, Hahn K, Möller HJ. Pharmacopsychiatry. 2008;41:169-175. (Impact Factor: 1.765) PMID: 18763218

Cerebral changes and cognitive dysfunctions in medication-free schizophrenia: an fMRI study. Scheuerecker J, Ufer S, Zipse M, Frodl T, Koutsouleris N, Zetzsche T, Wiesmann M, Albrecht J, Brückmann H, Schmitt G, Möller H-J, Meisenzahl E. Journal of Psychiatric Research. 2008;42:469-476. (Impact Factor: 4.183) PMID: 17559877

Hippocampal volume reduction and history of aggressive behaviour in patients with borderline personality disorder. Zetzsche T, Preuss UW, Frodl T, Schmitt G, Seifert D, Münchhausen E, Tabrizi S, Leinsinger G, Born C, Reiser M, Möller H-J, Meisenzahl EM.

Psychiatry Research: Neuroimaging. 2007;154:157-170. (Impact Factor: 1.878) PMID: 17306512

In-vivo topography of structural alterations of the anterior cingulate in patients with schizophrenia: new findings and comparison with the literature. Zetzsche T, Preuss UW, Frodl T, Watz D, Schmitt G, Koutsouleris N, Born C, Reiser M, Möller H-J., Meisenzahl EM. Schizophrenia Research. 2007; 96:34-45. (Impact Factor: 3.986) PMID: 17765479

Differential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depressive disorder. Juckel G, Pogarell O, Augustin H, Mulert C, Müller-Siecheneder F, Frodl T, Mavrogiorgou P, Hegerl U. J Clin Psychiatry. 2007;68:1206-1212. (Impact Factor: 5.230) PMID: 17854244

Hand-motor dysfunction in depression: characteristics and pharmacological effects. Mergl R, Pogarell O, Juckel G, Rihl J, Henkel V, Frodl T, Muller-Siecheneder F, Karner M, Tigges P, Schroter A, Hegerl U. Clin EEG Neurosci. 2007;38:82-88. (Impact Factor: 2.163) PMID: 17515173

In-vivo topography of structural alterations of the anterior cingulate in patients with schizophrenia: new findings and comparison with the literature. Zetzsche T, Preuss U, Frodl T, Watz D, Schmitt G, Koutsouleris N, Born C, Reiser M, Möller HJ, Meisenzahl EM. Schizophr Res. 2007;96:34-45. (Impact Factor: 3.986) PMID: 17765479

Cerebral differences in explicit and implicit emotional processing -an fMRI study. Scheuerecker J, Frodl T, Koutsouleris N, Zetzsche T, Wiesmann M, Kleemann A-M, Brückman H, Möller H-J, Meisenzahl E. Neuropsychobiology. 2007;56:32-39. (Impact Factor: 1.491) PMID: 17986835

Striatal dopamine transporter availability is associated with the productive psychotic state in first episode, drug-naive schizophrenic patients. Schmitt GJ, Frodl T, Dresel S, la Fougere C, Bottlender R, Koutsouleris N, Hahn K, Moller HJ, Meisenzahl EM. European Archives of Psychiatry and Clinical Neuroscience. 2006;256:115-121. (Impact Factor: 3.569) PMID: 16284713

Amygdala volume and depressive Symptoms in patients with borderline personality disorder. Zetzsche T, Frodl T, Preuss UW, Schmitt G, Seifert D, Leinsinger G, Born C, Reiser M, Moller HJ, Meisenzahl EM. Biological Psychiatry. 2006;60:302-310. (Impact Factor: 11.412) PMID: 16476409

Effects of treatment with the atypical neuroleptic quetiapine on working memory function: A functional MRI follow-up investigation. Meisenzahl E, Scheuerecker J, Zipse M, Ufer S, Wiesmann M, Frodl T, Koutsouleris N, Zetzsche T, Schmitt G, Riedel M, Spellmann I, Dehning S, Linn J, Brückmann H, Möller H-J. European Archives of Psychiatry and Clinical Neurosciences. 2006;256:522-531. (Impact Factor: 3.569) PMID: 17151834

D2 receptor occupancy during high- and low-dose therapy with the atypical antipsychotic amisulpride: a 123I-iodobenzamide SPECT study. la Fougere C, Meisenzahl E, Schmitt G, Stauss J, Frodl T, Tatsch K, Hahn K, Moller HJ, Dresel S. Journal of Nuclear Medicine. 2005;46:1028-1033. (Impact Factor: 6.646) PMID: 15937316

Thalamic volume in first-episode and chronic schizophrenic subjects: a volumetric MRI study. Preuss UW, Zetzsche T, Jager M, Groll C, Frodl T, Bottlender R, Leinsinger G, Hegerl U, Hahn K, Moller HJ, Meisenzahl EM. Schizophrenia Research. 2005;73:91-101. (Impact Factor: 3.986) PMID: 15567081

The striatal dopamine transporter in first-episode, drug-naive schizophrenic patients: evaluation by the new SPECT-ligand[99mTc]TRODAT-1. Schmitt GJ, Meisenzahl EM, Frodl T, La Fougere C, Hahn K, Moller HJ, Dresel S. Journal of Psychopharmacology. 2005;19:488-493. (Impact Factor: 4.179) PMID: 16166186

Superior temporal gyrus and P300 in schizophrenia: a combined ERP/structural magnetic resonance imaging investigation. Meisenzahl EM, Frodl T, Müller D, Schmitt G, Gallinat J, Zetzsche T, Marcuse A, Juckel G, Leinsinger G, Hahn K, Möller H-J, Hegerl U. Journal of Psychiatric Research. 2004;38:153-162. (Impact Factor: 4.183) PMID: 14757329

Loudness dependence of primary auditory-cortex-evoked activity as predictor of therapeutic outcome to prophylactic lithium treatment in affective disorders - a retrospective study. Juckel G, Mavrogiorgou P, Bredemeier S, Gallinat J, Frodl T, Schulz C, Möller HJ, Hegerl U. Pharmacopsychiatry. 2004;37:46-51. (Impact Factor: 1.765) PMID: 15048610

Differential effects of reboxetine and citalopram on hand motor function in patients suffering from major depression. Hegerl U, Mergl R, Henkel V, Pogarell O, Müller-Siecheneder F, Frodl T, Juckel G Psychopharmacology. 2005;178:58-66. (Impact Factor: 3.308) PMID: 15316714

The septum pellucidum and its variants. An MRI study. Born CM, Meisenzahl EM, Frodl T, Pfluger T, Reiser M, Moller HJ, Leinsinger GL. European Archives of Psychiatry and Clinical Neuroscience. 2004;254:295-302. (Impact Factor: 3.569) PMID: 15365704

Identification of a naturally occurring polymorphism in the promotor region of the norepinephrine transporter and analysis in major depression. Zill P, Engel R, Baghai TC, Juckel G, Frodl T, Müller-Siecheneder F, Zwanzger P, Schüle C, Minov C, Behrens S, Rupprecht R, Hegerl U, Möller H-J, Bondy B. Neuropsychopharmacology. 2002;26:489-493. (Impact Factor: 6.347) PMID: 11927173

Does the definition of borders of the planum temporale influence the results in schizophrenia? Meisenzahl EM, Zetzsche T, Preuss U, Frodl T, Leinsinger G, Möller H-J. American Journal of Psychiatry. 2002;159:1198-1200. (Impact Factor: 14.176) PMID:12091199

Striatal dopamine D2 receptor binding of risperidone in schizophrenic patients as assessed by ¹²³J-iodobenzamide SPECT: a comparative study with olanzapine. Schmitt GJE, Meisenzahl EM, Dresel S, Tatsch K, Rossmüller B, Frodl T, Preuss UW, Hahn K, Möller H-J. Journal of Psychopharmacology. 2002;16:200-206. (Impact Factor: 4.179) PMID: 12236625

Investigation of a possible diencephalic pathology in schizophrenia. Meisenzahl E, Frodl T, Zetzsche T, Leinsinger G, Maag K, Hegerl U, Hahn K, Möller H-J. Psychiatry Research: Neuroimaging. 2002;115:127-135. (Impact Factor: 1.878) PMID: 12208490

P300 subcomponents in obsessive-compulsive disorder. Mavrogiorgou P, Juckel G, Frodl T, Gallinat J, Hauke W, Zaudig M, Dammann G, Möller HJ, Hegerl U. Journal of Psychiatric Research. 2002;36:399-406. (Impact Factor: 4.183) PMID: 12393309

Handedness and corpus callosum morphology. Preuss UW, Meisenzahl EM, Frodl T, Zetzsche T, Holder J, Leinsinger G, Hegerl U, Hahn K, Möller HJ. Psychiatry Research: Neuroimaging. 2002;116:33-42. (Impact Factor: 1.878) PMID: 12426032

P300 and symptom improvement in schizophrenia. Gallinat J, Riedel M, Juckel G, Sokullu S, Frodl T, Moukhtieva R, Mavrogiorgou P, Nisslé S, Müller N, Danker-Hopfe H, Hegerl U. Psychopharmacology. 2001;158:55-65. (Impact Factor: 3.308). PMID: 11685384

Digitized analysis of abnormal hand-motor performance in schizophrenic patients. Tigges P, Mergl R, Frodl T, Meisenzahl EM, Gallinat J, Schröter A, Riedel M, Müller N, Möller H-J, Hegerl U. Schizophenia Research. 2000;45:133-143. (Impact Factor: 3.986) PMID: 10978881

Adhesio interthalamica in male patients with schizophrenia. Meisenzahl EM, Frodl T, Zetzsche T, Leinsinger G, Heiss D, Maag K, Hegerl U, Hahn K, Möller H-J. American Journal of Psychiatry. 2000;157:823-825. (Impact Factor: 14.176) PMID: 10784480

Loudness dependence of auditory evoked potentials in obsessive-compulsive disorder: a pilot study. Carilla-de-la-Pena MT, Mavrogiorgou P, Juckel G, Hauke W, Gallinat J, Frodl T, Zaudig M, Hegerl U. Psychiatry Research. 2000;93:209-216. (Impact Factor: 2.528) PMID: 10760379

Possible association between loudness dependence of auditory evoked potentials and tryptophan hydroxylase-alleles in alcoholics. Preuss UW, Bondy B, Zill P, Frodl T, Soyka M, Möller H-J, Hegerl U. Addiction Biology. 2000;5:297-305. (Impact Factor: 4.603) PMID: 20575844

D2 receptor occupancy under recommended and high doses of olanzapine: an iodine-123-iodobenzamide SPECT study. Meisenzahl EM, Dresel S, Frodl T, Schmitt GJE, Preuss UW, Rossmüller B, Tatsch K, Mager T, Hahn K, Möller H-J. Journal of Psychopharmacology. 2000;14:364-370. (Impact Factor: 3.308) PMID: 11198054

Stability of the mismatch negativity under different stimulus and attention conditions. Kathmann N, Frodl (Frodl-Bauch) T, Hegerl U. Clinical Neurophysiology. 1999;110:317-323. (Impact Factor: 3.866) PMID: 10210621

Late Auditory evoked potentials (P300) do not discriminate between subgroups of alcohol-dependent patients defined by family history and antisocial personality traits. Preuss UW, Frodl (Frodl-Bauch) T, Benda E, Soyka M, Möller H-J, Hegerl U. European Journal of Medical Research. 1999;4:114-120. (Impact Factor: 1.414). PMID: 10085279

Corpus callosum size in schizophrenia – a magnetic resonance imaging analysis. Meisenzahl EM, Frodl T, Greiner J, Leinsinger G, Maag K-P, Heiss D, Hahn K, Hegerl U, Möller H-J. European Archives of Psychiatry and Clinical Neuroscience. 1999;249:305-312. (Impact Factor: 3.569) PMID: 10653287